Angelica Sonzogni

Ripamonti, European Institute of Oncology

Papers

4

Total Citations

587

H-Index

4

About

Dr. Angelica Sonzogni is a pioneering colorectal surgeon whose work has fundamentally advanced the field of robotic surgery for rectal cancer. Her key research focuses on the technical refinement and oncological safety of robotic total mesorectal excision (TME), with a particular emphasis on preserving patient quality of life. Her most influential contribution is a landmark 2010 comparative study (236 citations) demonstrating that robotic TME is not only oncologically safe but also yields superior short-term outcomes compared to the laparoscopic approach. Dr. Sonzogni is also renowned for her groundbreaking prospective analysis (186 citations) of robotic surgery’s impact on sexual and urinary functions, providing critical evidence that the robotic platform can better preserve pelvic autonomic nerves. Her work on full robotic left colon and rectal resections (132 citations) established a reproducible technique, while her case-matched study on operative blood loss (33 citations) confirmed the procedure’s safety profile. By rigorously proving that robotic surgery can match or exceed open and laparoscopic outcomes while minimizing functional morbidity, Dr. Sonzogni has been instrumental in shifting the standard of care toward minimally invasive, nerve-sparing approaches for rectal cancer patients.

Research Focus

Key Achievements

4
H-Index
4
Papers
587
Total Citations
147
Avg Citations/Paper
🏆 Most Cited Paper
Robotic versus laparoscopic total mesorectal excision for rectal cancer: a comparative analysis of oncological safety and short-term outcomes
236 citations · 2010
📈 Most Prolific Year: 2010 (2 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: Ripamonti, European Institute of Oncology

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago